Author

H. Oliveira

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1 Organism:E. coli· 1 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Cunha· 1 shared A. Ferreira· 1 shared A. G. Castro· 1 shared A. G. Fraga· 1 shared A. Mora· 1 shared A. Oliveira· 1 shared C. Almeida· 1 shared C. Dias· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Cunha

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Studies on the interaction of three lytic bacteriophages with a wide collection of Escherichia coli strains implicated in swine enteric colibacillosis

A. Ferreira, C. Almeida, D. Silva, I. Garcia-Menino, A. Mora, H. Oliveira, A. Oliveira

This study evaluates three bacteriophages against ETEC and STEC strains from swine, finding they have narrow lytic spectra and some exhibit unique receptor recognition.

bioRxiv · Jul 4, 2022 · PreprintMicrobiology

Identifying relationships between imaging phenotypes and lung cancer-related mutation status: EGFR and KRAS

G. Pinheiro, T. Pereira, C. Dias, C. Freitas, V. Hespanhol, J. L. Costa, A. Cunha, H. Oliveira

The paper explores correlations between imaging phenotypes and EGFR/KRAS mutation status in lung cancer using high-dimensional visualization and classifiers, finding potential links for EGFR but not KRAS.

bioRxiv · Oct 11, 2019Bioengineering

Antimicrobial activity of Mycobacteriophage D29 Lysin B during Mycobacterium ulcerans infection

A. G. Fraga, G. Trigo, J. Dominguez, R. Silva-Gomes, C. M. Goncalves, H. Oliveira, A. G. Castro, J. Azeredo, J. Pedrosa

This study shows that recombinant Lys B, a phage-encoded enzyme, reduces M. ulcerans bacterial burdens in mice and induces immune responses, suggesting its potential as a new therapeutic for Buruli Ulcer.

bioRxiv · Dec 27, 2018Microbiology